NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
-1.97%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.1B
AUM Growth
+$2.1B
(+3.3%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
64.85%
Holding
56
New
2
Increased
9
Reduced
13
Closed
4
Top Buys
| 1 |
Cable One
CABO
|
$30.3M |
| 2 |
Corcept Therapeutics
CORT
|
$20.5M |
| 3 |
Salesforce
CRM
|
$14.4M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.3M |
| 5 |
Kezar Life Sciences
KZR
|
$5.15M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$67.6M |
| 2 |
Nkarta
NKTX
|
$17.9M |
| 3 |
Brookfield
BN
|
$16.9M |
| 4 |
Arcellx
ACLX
|
$15.5M |
| 5 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$12.3M |
Sector Composition
| 1 | Healthcare | 51.95% |
| 2 | Technology | 13.97% |
| 3 | Financials | 4.89% |
| 4 | Communication Services | 3.25% |
| 5 | Consumer Discretionary | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aligos Therapeutics
ALGS
$73.8M
| $2.15M | 0.1% |
1,950,000
| – | – |
|
52
Spero Therapeutics
SPRO
$115M
| $938K | 0.04% |
468,902
| – | – |
|
53
Inogen
INGN
$219M
| – | – |
-462,949
| Closed | -$11.2M |
|
|
VRNA
54
Verona Pharma
VRNA
$9.18B
| – | – |
-761,205
| Closed | -$3.19M |
|
|
MORF
55
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-565,237
| Closed | -$12.3M |
|
|
AKUS
56
DELISTED
Akouos, Inc. Common Stock
AKUS
| – | – |
-1,061,990
| Closed | -$4.98M |
|